Squarepoint’s Avita Medical RCEL Stock Holding History

Squarepoint’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,452	Closed	-$114K	–	4593
2024 Q2	$114K	Buy	+14,452	New	+$137K	﹤0.01%	3771
2023 Q4	–	Sell	-18,683	Closed	-$273K	–	4399
2023 Q3	$273K	Buy	+18,683	New	+$316K	﹤0.01%	3235
2023 Q2	–	Sell	-16,073	Closed	-$225K	–	3927
2023 Q1	$225K	Buy	16,073 +6,056	+60%	+$64.4K	﹤0.01%	2734
2022 Q4	$66.1K	Buy	+10,017	New	+$60K	﹤0.01%	3019
2022 Q3	–	Sell	-13,279	Closed	-$63K	–	3353
2022 Q2	$63K	Buy	+13,279	New	+$82K	﹤0.01%	2686

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's RCEL Position: Q3 2024 in Review

Squarepoint sold out of Avita Medical (RCEL) in Q3 2024, closing a stake of 14,452 shares — an estimated $114K sold.

Squarepoint first reported a position in RCEL in Q2 2022 and held it in 5 quarters. The position peaked at $273K in Q3 2023. 67 funds tracked by Wall St. Rank hold RCEL as of Q3 2024.

Squarepoint reported no remaining Avita Medical position as of Q3 2024 after selling out during the quarter.
Squarepoint sold 14,452 Avita Medical shares in Q3 2024, an estimated $114K.
Squarepoint first reported a position in Avita Medical in Q2 2022 and held it in 5 quarters.
Squarepoint's Avita Medical position peaked at $273K in Q3 2023.
67 funds tracked by Wall St. Rank held Avita Medical as of Q3 2024.

Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.